Last checked at 
(Sharecast News) - Self-care company Venture Life said on Tuesday that it was "confident" that it would comfortably exceed market expectations for the current year.
Venture Life said its order book was "significantly ahead" of where it was at at the same time one year ago and highlighted the signing of an exclusive €168m agreement with an existing partner, with orders in excess of €7m for delivery in 2020.
At the same time, the AIM-listed group said all other areas of the business had traded well and noted that its hand sanitising gel brand was seeing "good demand".
Venture Life also said it was positive following an extension to its commercial relationship with Alliance Pharma, which currently runs until the end of 2026.
Chief executive Jerry Randall said: "I am proud of how the company has operated through a challenging period and am delighted with our performance this year.
He added that the group had: "Not only kept our business operating in very difficult circumstances but have also continued to grow the business and bring more opportunities into the group."
As of 0920 BST, Venture Life shares were up 8.05% at 70.77p.
19 Apr 2022 12:02
TRADING UPDATES: Cerillion profit up; Iofina says iodine demand strong
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more